Detecting µ Opioid Receptor with New Antibody
Author Information
Author(s): Kasai Shinya, Yamamoto Hideko, Kamegaya Etsuko, Uhl George R, Sora Ichiro, Watanabe Masahiko, Ikeda Kazutaka
Primary Institution: Tokyo Institute of Psychiatry
Hypothesis
The study aims to evaluate the effectiveness of a new anti-MOP antibody for detecting µ opioid receptor expression levels.
Conclusion
The new N38 antibody effectively detects µ opioid receptor proteins in brain samples, showing specific bands in wildtype but not in knockout mice.
Supporting Evidence
- The N38 antibody detected specific bands in wildtype brain samples but not in MOP knockout samples.
- The study demonstrated that the N38 antibody is more suitable for quantitative assays of MOP protein levels.
- MOP expression is altered in substance dependence, making accurate detection important for research.
Takeaway
Researchers created a new tool to see how much of a specific brain protein is present, which helps understand how drugs affect the brain.
Methodology
The study used Western blot analysis with a newly developed anti-MOP antibody on brain lysates from both wildtype and MOP knockout mice.
Limitations
The study does not address potential nonspecific immunoreactivity of the N38 antibody.
Participant Demographics
C57BL/6J mice and MOP knockout mice were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website